| |
| |
|
| Insider
Information: |
Swain Judith L |
| Relationship: |
Director |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
48,364 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$94,310 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,364 |
|
|
| Total
Value |
$94,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
Director |
2024-04-28 |
48,364 |
2012-04-27 |
0 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Director |
2023-06-16 |
0 |
2023-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • – |
2012-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,764 |
11,764 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2013-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,101 |
21,865 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2014-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,820 |
34,685 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,691 |
53,376 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2016-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,432 |
9,057 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2017-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,281 |
10,338 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2018-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,564 |
12,902 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2020-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,466 |
16,368 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2021-04-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,638 |
27,006 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,024 |
31,030 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,071 |
2,071 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2023-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,302 |
40,332 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,071) |
0 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2024-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,032 |
48,364 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
